| 2.37 -0.17 (-6.69%) | 11-19 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 10.86 | 1-year : | 15.97 |
| Resists | First : | 9.3 | Second : | 13.68 |
| Pivot price | 2.84 |
|||
| Supports | First : | 2.23 | Second : | 1.85 |
| MAs | MA(5) : | 2.52 |
MA(20) : | 3.66 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -1.5  |
Signal : | -1.5 |
| %K %D | K(14,3) : | 15.2 |
D(3) : | 12.9 |
| RSI | RSI(14): 28.7 |
|||
| 52-week | High : | 13.68 | Low : | 2.23 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PMI ] has closed above bottom band by 8.2%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 2.64 - 2.66 | 2.66 - 2.68 |
| Low: | 2.3 - 2.32 | 2.32 - 2.34 |
| Close: | 2.34 - 2.38 | 2.38 - 2.4 |
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc.
Wed, 19 Nov 2025
SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart - The Manila Times
Wed, 19 Nov 2025
Picard (NYSE: PMI) first in vivo Emperor total artificial heart implants - Stock Titan
Mon, 27 Oct 2025
Picard Medical, Inc. Addresses Stock Price Volatility - TradingView
Mon, 27 Oct 2025
Arizona biotech firm's shares nosedive after expansion of equity incentives - The Business Journals
Sat, 25 Oct 2025
Picard Medical (PMI): Valuation Reassessed After Equity Plan Sparks Dilution Concerns and Stock Drop - simplywall.st
Sat, 25 Oct 2025
Picard Medical’s Stock Plummets Amid Concerns Over Muted Trading Session - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|